| Spotlight |
 |
|
RLTs were a hot topic at ASCO 2026, but experts note that certain limitations must be addressed to facilitate their widespread use in cancer care.
|
| Latest news |
|
|
The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.
|
|
|
Experts note that adherence-focused health technologies should be flexible, engaging, adaptable and affordable to the patient or healthcare system.
|
|
|
Sun Pharma expects to close the acquisition on or before 31 July 2026.
|
|
|
The approved indications include combining Sarclisa SC with Pd, or with carfilzomib for relapsed or refractory multiple myeloma.
|
|
|
GlobalData says that the industry has “absorbed significant disruption”, with high M&A levels testament to recovery.
|
|
|
|
